190 related articles for article (PubMed ID: 33577435)
1. FoxO1 is required for physiological cardiac hypertrophy induced by exercise but not by constitutively active PI3K.
Weeks KL; Tham YK; Yildiz SG; Alexander Y; Donner DG; Kiriazis H; Harmawan CA; Hsu A; Bernardo BC; Matsumoto A; DePinho RA; Abel ED; Woodcock EA; McMullen JR
Am J Physiol Heart Circ Physiol; 2021 Apr; 320(4):H1470-H1485. PubMed ID: 33577435
[TBL] [Abstract][Full Text] [Related]
2. Phosphoinositide 3-kinase p110α is a master regulator of exercise-induced cardioprotection and PI3K gene therapy rescues cardiac dysfunction.
Weeks KL; Gao X; Du XJ; Boey EJ; Matsumoto A; Bernardo BC; Kiriazis H; Cemerlang N; Tan JW; Tham YK; Franke TF; Qian H; Bogoyevitch MA; Woodcock EA; Febbraio MA; Gregorevic P; McMullen JR
Circ Heart Fail; 2012 Jul; 5(4):523-34. PubMed ID: 22705768
[TBL] [Abstract][Full Text] [Related]
3. Insulin-like growth factor I receptor signaling is required for exercise-induced cardiac hypertrophy.
Kim J; Wende AR; Sena S; Theobald HA; Soto J; Sloan C; Wayment BE; Litwin SE; Holzenberger M; LeRoith D; Abel ED
Mol Endocrinol; 2008 Nov; 22(11):2531-43. PubMed ID: 18801929
[TBL] [Abstract][Full Text] [Related]
4. Phosphoinositide dependent protein kinase 1 is required for exercise-induced cardiac hypertrophy but not the associated mitochondrial adaptations.
Noh J; Wende AR; Olsen CD; Kim B; Bevins J; Zhu Y; Zhang QJ; Riehle C; Abel ED
J Mol Cell Cardiol; 2015 Dec; 89(Pt B):297-305. PubMed ID: 26476238
[TBL] [Abstract][Full Text] [Related]
5. Atrogin-1 inhibits Akt-dependent cardiac hypertrophy in mice via ubiquitin-dependent coactivation of Forkhead proteins.
Li HH; Willis MS; Lockyer P; Miller N; McDonough H; Glass DJ; Patterson C
J Clin Invest; 2007 Nov; 117(11):3211-23. PubMed ID: 17965779
[TBL] [Abstract][Full Text] [Related]
6. The FOXO3a transcription factor regulates cardiac myocyte size downstream of AKT signaling.
Skurk C; Izumiya Y; Maatz H; Razeghi P; Shiojima I; Sandri M; Sato K; Zeng L; Schiekofer S; Pimentel D; Lecker S; Taegtmeyer H; Goldberg AL; Walsh K
J Biol Chem; 2005 May; 280(21):20814-23. PubMed ID: 15781459
[TBL] [Abstract][Full Text] [Related]
7. Oleic Acid Protects from Arsenic-Induced Cardiac Hypertrophy via AMPK/FoxO/NFATc3 Pathway.
Samanta J; Mondal A; Saha S; Chakraborty S; Sengupta A
Cardiovasc Toxicol; 2020 Jun; 20(3):261-280. PubMed ID: 31571030
[TBL] [Abstract][Full Text] [Related]
8. Gene therapy targeting cardiac phosphoinositide 3-kinase (p110α) attenuates cardiac remodeling in type 2 diabetes.
Prakoso D; De Blasio MJ; Tate M; Kiriazis H; Donner DG; Qian H; Nash D; Deo M; Weeks KL; Parry LJ; Gregorevic P; McMullen JR; Ritchie RH
Am J Physiol Heart Circ Physiol; 2020 Apr; 318(4):H840-H852. PubMed ID: 32142359
[TBL] [Abstract][Full Text] [Related]
9. Akt2 ablation prolongs life span and improves myocardial contractile function with adaptive cardiac remodeling: role of Sirt1-mediated autophagy regulation.
Ren J; Yang L; Zhu L; Xu X; Ceylan AF; Guo W; Yang J; Zhang Y
Aging Cell; 2017 Oct; 16(5):976-987. PubMed ID: 28681509
[TBL] [Abstract][Full Text] [Related]
10. Foxo transcription factors blunt cardiac hypertrophy by inhibiting calcineurin signaling.
Ni YG; Berenji K; Wang N; Oh M; Sachan N; Dey A; Cheng J; Lu G; Morris DJ; Castrillon DH; Gerard RD; Rothermel BA; Hill JA
Circulation; 2006 Sep; 114(11):1159-68. PubMed ID: 16952979
[TBL] [Abstract][Full Text] [Related]
11. Galectin-3 mediates cardiac remodeling caused by impaired glucose and lipid metabolism through inhibiting two pathways of activating Akt.
Sun Z; Zhang L; Li L; Shao C; Liu J; Zhou M; Wang Z
Am J Physiol Heart Circ Physiol; 2021 Jan; 320(1):H364-H380. PubMed ID: 33275526
[TBL] [Abstract][Full Text] [Related]
12. Genomic Binding Patterns of Forkhead Box Protein O1 Reveal Its Unique Role in Cardiac Hypertrophy.
Pfleger J; Coleman RC; Ibetti J; Roy R; Kyriazis ID; Gao E; Drosatos K; Koch WJ
Circulation; 2020 Sep; 142(9):882-898. PubMed ID: 32640834
[TBL] [Abstract][Full Text] [Related]
13. Autophagy plays an essential role in mediating regression of hypertrophy during unloading of the heart.
Hariharan N; Ikeda Y; Hong C; Alcendor RR; Usui S; Gao S; Maejima Y; Sadoshima J
PLoS One; 2013; 8(1):e51632. PubMed ID: 23308102
[TBL] [Abstract][Full Text] [Related]
14. CD38 promotes angiotensin II-induced cardiac hypertrophy.
Guan XH; Hong X; Zhao N; Liu XH; Xiao YF; Chen TT; Deng LB; Wang XL; Wang JB; Ji GJ; Fu M; Deng KY; Xin HB
J Cell Mol Med; 2017 Aug; 21(8):1492-1502. PubMed ID: 28296029
[TBL] [Abstract][Full Text] [Related]
15. STIM1 ablation impairs exercise-induced physiological cardiac hypertrophy and dysregulates autophagy in mouse hearts.
Bonilla IM; Baine S; Pokrass A; Mariángelo JIE; Kalyanasundaram A; Bogdanov V; Mezache L; Sakuta G; Beard CM; Belevych A; Tikunova S; Terentyeva R; Terentyev D; Davis J; Veeraraghavan R; Carnes CA; Györke S
J Appl Physiol (1985); 2023 May; 134(5):1287-1299. PubMed ID: 36995910
[TBL] [Abstract][Full Text] [Related]
16. Glucose transporter 4-deficient hearts develop maladaptive hypertrophy in response to physiological or pathological stresses.
Wende AR; Kim J; Holland WL; Wayment BE; O'Neill BT; Tuinei J; Brahma MK; Pepin ME; McCrory MA; Luptak I; Halade GV; Litwin SE; Abel ED
Am J Physiol Heart Circ Physiol; 2017 Dec; 313(6):H1098-H1108. PubMed ID: 28822962
[TBL] [Abstract][Full Text] [Related]
17. Enhanced phosphoinositide 3-kinase(p110α) activity prevents diabetes-induced cardiomyopathy and superoxide generation in a mouse model of diabetes.
Ritchie RH; Love JE; Huynh K; Bernardo BC; Henstridge DC; Kiriazis H; Tham YK; Sapra G; Qin C; Cemerlang N; Boey EJ; Jandeleit-Dahm K; Du XJ; McMullen JR
Diabetologia; 2012 Dec; 55(12):3369-81. PubMed ID: 23001375
[TBL] [Abstract][Full Text] [Related]
18. Deletion of ribosomal S6 kinases does not attenuate pathological, physiological, or insulin-like growth factor 1 receptor-phosphoinositide 3-kinase-induced cardiac hypertrophy.
McMullen JR; Shioi T; Zhang L; Tarnavski O; Sherwood MC; Dorfman AL; Longnus S; Pende M; Martin KA; Blenis J; Thomas G; Izumo S
Mol Cell Biol; 2004 Jul; 24(14):6231-40. PubMed ID: 15226426
[TBL] [Abstract][Full Text] [Related]
19. Phosphoinositide 3-kinase(p110alpha) plays a critical role for the induction of physiological, but not pathological, cardiac hypertrophy.
McMullen JR; Shioi T; Zhang L; Tarnavski O; Sherwood MC; Kang PM; Izumo S
Proc Natl Acad Sci U S A; 2003 Oct; 100(21):12355-60. PubMed ID: 14507992
[TBL] [Abstract][Full Text] [Related]
20. Opposing roles of Akt and STAT3 in the protection of the maternal heart from peripartum stress.
Ricke-Hoch M; Bultmann I; Stapel B; Condorelli G; Rinas U; Sliwa K; Scherr M; Hilfiker-Kleiner D
Cardiovasc Res; 2014 Mar; 101(4):587-96. PubMed ID: 24448315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
